| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |